Our Services
Afrere Medical Solutions provides a full range of diagnostic testing designed to deliver accurate, timely, and actionable results. From toxicology and pharmacogenetics to infectious disease and wellness testing, our services empower healthcare providers and patients with the information they need to make informed decisions and improve outcomes.
Toxicology and Drug Testing
Presumptive Urine Drug Screening
Rapid qualitative tests to detect the presence of commonly abused substances.
This screening is a rapid, qualitative test used to detect the presence of commonly abused substances. It provides an initial assessment to help providers quickly determine if further confirmatory testing is needed. These screenings are essential in clinical settings, pain management, and workplace testing programs.
Our presumptive urine drug screening provides rapid, qualitative results to detect the presence of commonly abused substances such as opioids, benzodiazepines, amphetamines, and cannabinoids. This type of testing is critical for pain management programs, addiction treatment centers, and workplace compliance. By delivering quick results, providers can make immediate decisions about patient care, ensuring safety and compliance while minimizing delays in treatment.
Urine Drug Confirmation Testing
Highly sensitive methods to confirm specific drugs and their metabolites in urine samples.
When presumptive results require verification, urine drug confirmation testing offers highly sensitive and specific methods to identify exact drugs and their metabolites. Using advanced laboratory technology, this testing ensures precision and reduces the chance of false positives, providing providers with the confidence to make informed treatment decisions.
When accuracy is non-negotiable, Afrere Medical Solutions offers advanced urine drug confirmation testing. Using highly sensitive technology such as liquid chromatography–mass spectrometry (LC-MS/MS), our confirmatory tests identify specific drugs and their metabolites with precision. This eliminates the uncertainty of false positives and provides legally defensible results when required for compliance, employment verification, or medical-legal cases. Providers can trust our confirmation testing to support safe prescribing practices and improve patient outcomes.
Urine Validity Testing
Assessments to determine if a urine sample is suitable for drug testing by checking for signs of adulteration, substitution, or dilution
To ensure the integrity of test samples, urine validity testing checks for signs of adulteration, substitution, or dilution. This process guarantees that results are trustworthy and accurate, protecting both providers and patients from misleading information.
Integrity matters in toxicology testing. Our urine validity testing ensures that every sample is authentic, unadulterated, and suitable for analysis. By checking for dilution, substitution, or chemical adulteration, we protect the accuracy of toxicology results and safeguard clinical and workplace programs from misleading or manipulated outcomes. This service strengthens compliance programs and enhances confidence in testing protocols.
Molecular PCR Testing
Nail Fungus Testing
PCR technology to detect and identify fungal pathogens causing nail infections.
Nail infections can be difficult to diagnose visually. PCR technology allows for the accurate detection and identification of fungal pathogens causing nail infections. Early and precise identification helps providers prescribe the right treatment, improving outcomes and reducing unnecessary therapies.
Fungal nail infections are often misdiagnosed when assessed by sight alone. Afrere Medical Solutions uses advanced PCR technology to detect and identify fungal pathogens at the DNA level. This precise method eliminates guesswork, allowing providers to prescribe the most effective antifungal therapy while reducing unnecessary use of medications. Early and accurate diagnosis prevents worsening infections and supports faster recovery for patients.
Wound Care Testing
Molecular PCR testing to assess and monitor wound infections with exceptional accuracy.
Chronic and acute wounds can harbor multiple pathogens. Molecular PCR wound care testing identifies bacterial and fungal organisms with exceptional accuracy, enabling tailored treatment plans that accelerate healing and prevent complications such as antibiotic resistance.
Chronic wounds are complex and often host multiple bacterial and fungal organisms. Our PCR wound care testing offers exceptional sensitivity and specificity, identifying pathogens that may not be detected by traditional cultures. With results available in hours instead of days, providers can tailor antibiotic and antifungal therapies to each patient’s needs, promoting healing, reducing hospital readmissions, and lowering the risk of antibiotic resistance.
Urinary Tract Infection (UTI) Testing
Rapid and accurate detection of urinary tract infections, enabling prompt identification of causative pathogens.
PCR-based UTI testing delivers rapid and precise results, detecting the causative pathogens behind urinary tract infections. This technology ensures providers can quickly select the most effective treatment, reducing recovery time and improving patient comfort.
UTIs are among the most common infections, yet standard cultures can take days to deliver results. Afrere’s PCR UTI testing provides rapid, same-day detection of the pathogens causing infection. By identifying the specific bacteria and their resistance genes, we empower providers to prescribe targeted treatments that work the first time—reducing recurring infections, preventing complications, and improving patient comfort.
Sexually Transmitted Infection Testing
Precise and confidential molecular PCR testing for a wide range of sexually transmitted infections.
Confidential and accurate, PCR STI testing screens for a wide range of sexually transmitted infections with high sensitivity. Early detection is critical for effective treatment, reducing transmission, and safeguarding long-term health.
Early detection is critical in managing sexually transmitted infections. Afrere offers PCR-based STI testing that screens for a comprehensive panel of infections, including chlamydia, gonorrhea, trichomonas, mycoplasma, and more. Our confidential testing delivers highly accurate results quickly, supporting providers in offering timely treatment and counseling while helping patients safeguard their long-term reproductive health.
COVID-19 and Influenza Testing
Combined testing for the simultaneous detection of SARS-CoV-2 and common influenza viruses.
Combined PCR testing allows for the simultaneous detection of SARS-CoV-2 and common influenza viruses. This dual testing approach saves time, prevents misdiagnosis, and helps providers deliver the right treatment quickly—especially during peak flu and COVID seasons.
Respiratory illnesses often present with similar symptoms, making accurate testing essential. Afrere provides combined PCR testing that can simultaneously detect SARS-CoV-2 and common influenza strains. This dual approach eliminates diagnostic uncertainty, prevents unnecessary treatments, and enables timely infection control measures. Providers can act quickly to protect patients and communities, particularly during flu and COVID-19 peak seasons.